SITAGLIPTIN-TANNAT-KOMPLEXE

European patent · EP3131631 · In force

Register entry

Publication number
EP3131631
Application number
EP15780045
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 13, 2015
Published
Feb 22, 2017
Granted
Nov 16, 2022
Protection ends at the latest
Apr 12, 2035
Next annual fee due
Apr 30, 2027
IPC classes
A61P 3/08 (2006.01)
C07D 487/04 (2006.01)
A61K 31/4985 (2006.01)
A61K 31/496 (2006.01)
A61K 31/7032 (2006.01)
A61K 9/00 (2006.01)
A61K 45/06 (2006.01)
Priority
US 201461980641 P 17.04.2014
PCT application
PCT/US2015/025504 13.04.2015
PCT publication
WO2015/160678 22.10.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Sep 27, 2023

    Change

    Published in Swissreg on 27.09.2023

  5. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  6. Dec 22, 2022

    Agent entered

    Representative
    Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 22.12.2022

  7. Nov 16, 2022

    Granted

    Published in Swissreg on 16.11.2022

Parties

Holder

Merck Sharp & Dohme LLC

126 East Lincoln Avenue, Rahway, New Jersey 07065, US

Agent

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventor

BURLAGE, Rubi

Kenilworth, New Jersey 07033, US

OMWANCHA, Wycliffe

Kenilworth, New Jersey 07033, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.